Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
less decrease » teer decrease (Expand Search), we decrease (Expand Search), levels decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
less decrease » teer decrease (Expand Search), we decrease (Expand Search), levels decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
721
-
722
-
723
<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate....
Published 2025“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”
-
724
Survival function analysis of mortality for Viral load status and Treatment Interruption status.
Published 2025Subjects: -
725
-
726
-
727
Survival function analysis of treatment Interruption for Viral load status and BMI status.
Published 2025Subjects: -
728
Survival function analysis of viral suppression for BMI status and Treatment Interruption status.
Published 2025Subjects: -
729
-
730
-
731
-
732
-
733
-
734
-
735
-
736
Survival function analysis for LTFU according to Viral Load status and BMI status.
Published 2025Subjects: -
737
-
738
Annual incidence rate per 100 person-years trend for ART treatment outcomes.
Published 2025Subjects: -
739
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
-
740